Chapter 6: TUMOR PROMOTION — MECHANISMS AND IMPLICATION TO RISK ESTIMATION
- 1 September 1984
- journal article
- review article
- Published by Wiley in Acta Pharmacologica et Toxicologica
- Vol. 55 (S2) , 89-106
- https://doi.org/10.1111/j.1600-0773.1984.tb02484.x
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Characterization of a human placental factor which inhibits specific binding of phorbol esters to cultured cellsCarcinogenesis: Integrative Cancer Research, 1984
- Tumor Promotion by Phorbol Esters in Skin: Evidence for a Memory EffectScience, 1983
- Limiting factors of the V79 cell metabolic cooperation assay for tumor promotersCarcinogenesis: Integrative Cancer Research, 1983
- A New Tumor-Promoting Agent, Dihydroteleocidin B, Markedly Enhances Chemically Induced Malignant Cell TransformationScience, 1982
- Elimination of metabolic co-operation and the induction of sister chromatid exchanges are not properties common to all promoting or co-carcinogenic agentsCarcinogenesis: Integrative Cancer Research, 1982
- Inhibition of intercellular communication between liver cells by the liver tumor promoter 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethaneCancer Letters, 1981
- Factors influencing the induction of sister chromatid exchanges in mammalian cells by 12-O-tetradecanoyl-phorbol-13-acetateCarcinogenesis: Integrative Cancer Research, 1981
- Antipain and 12-O-tetradecanoyl-phorbol-13-acetate: Phenomenology of effects on UV mutagenesis in V79 Chinese hamster cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1980
- Tumor promoters inhibit metabolic cooperation in cocultures of epidermal and 3T3 cellsBiochemical and Biophysical Research Communications, 1979
- Transformation of C3H/10T1/2 CL8 mouse embryo fibroblasts by ultraviolet irradiation and a phorbol esterNature, 1976